# Standard Biotools Inc.: Form 10-K for the period ended Dec 31, 2011

- Company: [Standard Biotools Inc.](/companies/lab.md) (CIK 1162194)
- Form: 10-K
- Filed: 2012-03-26
- Accepted by EDGAR: Mar 23, 2012, 20:34 ET
- Period: 2011-12-31
- Accession: 0001193125-12-130255
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1162194/000119312512130255/d278425d10k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1162194/000119312512130255/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2011-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2011-01-01 to 2011-12-31 | $42.9m | us-gaap:Revenues |
| Research and development | 12 months, 2011-01-01 to 2011-12-31 | $13.9m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months, 2011-01-01 to 2011-12-31 | $31.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months, 2011-01-01 to 2011-12-31 | −$18.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2011-01-01 to 2011-12-31 | $3.1m | us-gaap:InterestExpense |
| Income tax | 12 months, 2011-01-01 to 2011-12-31 | $166.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2011-01-01 to 2011-12-31 | −$22.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2011-01-01 to 2011-12-31 | −$1.81 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 12 months, 2011-01-01 to 2011-12-31 | −$17.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2011-01-01 to 2011-12-31 | $1.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2011-12-31 | $13.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2011-12-31 | $70.0m | us-gaap:AssetsCurrent |
| Total assets | at 2011-12-31 | $79.3m | us-gaap:Assets |
| Current liabilities | at 2011-12-31 | $20.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2011-12-31 | $22.4m | us-gaap:Liabilities |
| Long-term debt | at 2011-12-31 | $1.2m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2011-12-31 | $8.9m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2011-12-31 | $56.9m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1162194/000119312512130255/d278425d10k.htm

Filed Mar 26, 2012.
Source: SEC EDGAR, the filing index for accession 0001193125-12-130255. Last ingested by Listed: Nov 5, 2026, 21:16 ET. No prices; not investment advice.
